Stimulates Insulin Secretion GLP-1 enhances the release of insulin from the pancreas in response to food intake
Finally, due to the small number of events occurring across studies, the results for severe gastrointestinal AEs and discontinuation outcomes were particularly sensitive to small differences in events and allow for broad comparisons only
Hydration between meals: Drinking water throughout the day helps manage constipation, a common side effect
View titration schedule Weeks 1-4 0.25 mg weekly Adaptation phase
The effects of ER once-weekly have been compared to exenatide twice-daily and overall ER was more effective at improving glycemic control and caused less gastrointestinal side-effects although both compounds caused a similar degree of weight loss (Drucker et al., The efficacy of once-weekly ER (2 mg) was compared to that of once-daily liraglutide (1.8 mg) in a 26-week trial in T2DM patients (Buse et al., DPP-4 inhibitors The DPP-4 inhibitors mediate their action by inhibiting the enzyme DPP-4, which prevents the breakdown of GLP-1 and thereby increases endogenous GLP-1 levels
For those unsure if their insurance covers semaglutide or other medications like tirzepatide or orforglipron, Klinic provides clarity before starting your treatment